Moderna | MRNA - Market Capitalization


Moderna reported $56.78B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pharma Mar EUR 1.31B 263.2M Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 65.93B 25.23B Jun/2026